|
|
|
|
12 Nov 2008 09:04:00 UTC
Breast cancer research treatment: Komen Breast Cancer Foundation and the National Philanthropic Trust which fund breast cancer research breast cancer research treatment, education breast cancer research treatment, screening and treatment. Deutsche Post World Net breast cancer research treatment, the parent
|
|
11 Nov 2008 09:41:40 UTC
Breast cancer research treatment: Partial Breast Irradiation Now Provided by Rocky Mountain Oncology MarketWatch - 5 hours ago This ground-breaking treatment breast cancer research treatment, offers many patients with early-stage breast cancer a new treatment option. Partial breast irradiation can be offered
|
|
10 Nov 2008 03:38:12 UTC
Breast cancer research treatment: NeoPharm, Inc. Announces Third Quarter 2008 Financial Results MarketWatch - 1 hour ago NeoPharm has begun enrolling patients at TGen Clinical Research Services at Scottsdale Healthcare and at The Lombardi Comprehensive Cancer Center at Adherex Reports Third Quarter 2008 Financial Results FOXBusiness all 22 news articles
|
09 Nov 2008 12:05:52 UTC
Breast cancer research treatment: The lives of real patients; the politics of breast cancer activism, funding and research; the charismatic The cited statistics on recurrence and the effectiveness of treatment
|
08 Nov 2008 16:20:25 UTC
Breast cancer research treatment: Partial Breast Irradiation Now Provided breast cancer research treatment by Rocky Mountain Oncology MarketWatch - breast cancer research treatment 5 hours ago This ground-breaking treatment , offers breast cancer research treatment many patients with early-stage breast breast cancer research treatment cancer a new treatment option. Partial breast cancer research treatment breast irradiation can be offered
|
07 Nov 2008 19:05:32 UTC
Breast cancer research treatment: aromatase inhibitor licensed for primary adjuvant treatment of breast cancer San Antonio Breast Cancer Symposium 2005. [2] Cancer Research UK website. http://www.cancerresearchuk
|
06 Nov 2008 20:06:12 UTC
Breast cancer research treatment: AFP Scientists Unravel Mystery of Tamoxifen Resistance U.S. News & World Report, DC - 4 hours ago "Given the fact that tamoxifen is such a commonly prescribed drug for the treatment of breast cancer breast cancer research treatment, understanding how it works and what happens when it Genetic clue could lead to better breast cancer drugs Daily Mail Resistance to Common Breast Cancer Drug Connected to Protein Bloomberg Scientists unravel breast cancer drug resistance Reuters UK The Associated Press - WSLS.com all 197 news articles
|
05 Nov 2008 13:36:56 UTC
Breast cancer research treatment: aromatase inhibitor licensed for primary adjuvant treatment of breast cancer San Antonio Breast Cancer Symposium 2005. [2] Cancer Research UK website. http://www.cancerresearchuk
|
|
|
|
|